COMPARATIVE EFFICACY OF BETAMETHASONE CLIOQUINOL (BETNOVATE-C) CREAM AND BETAMETHASONE FUSIDIC ACID (FUCIBET) CREAM IN THE TREATMENT OF INFECTED HAND ECZEMA/
Va. Hill et al., COMPARATIVE EFFICACY OF BETAMETHASONE CLIOQUINOL (BETNOVATE-C) CREAM AND BETAMETHASONE FUSIDIC ACID (FUCIBET) CREAM IN THE TREATMENT OF INFECTED HAND ECZEMA/, Journal of dermatological treatment, 9(1), 1998, pp. 15-19
The efficacy, tolerability and acceptability of betamethasone valerate
0.1%/fusidic acid 2% cream and betamethasone valerate 0.1%/clioquinol
3% cream were compared in 120 patients of either sex, aged 18 years o
r over, with a clinical diagnosis of infected hand eczema. Both creams
were applied twice daily for up to 4 weeks. Assessments were made by
the investigator and by the patient at baseline and at 1, 2 and 4 week
s. Swabs were taken for bacteriological culture at baseline and at the
end of treatment. Overall, both creams were similarly effective clini
cally, with 57.9% of patients given betamethasone/clioquinol and 60.4%
of patients given betamethasone/fusidic acid responding (NS; 95% conf
idence interval for difference -16.1, 21.2). However, betamethasone/fu
sidic acid cream gave a significantly better bacteriological response
(P < 0.005). Both treatments were well tolerated. Betamethasone/fusidi
c acid cream was considered by the patients to be a significantly more
cosmetically acceptable treatment (P < 0.0001).